Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Borderline Resectable Pancreatic Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01897454
What this trial is testing

Gemcitabine Hydrochloride, and Radiation Therapy in Patients With Borderline Resectable Pancreatic Cancer

Who this might be right for
Pancreatic AdenocarcinomaStage IIA Pancreatic CancerStage IIB Pancreatic Cancer+1 more
Albert Einstein College of Medicine 23
Early research (Phase 1)Study completedNCT04106856
What this trial is testing

Losartan and Hypofractionated Rx After Chemo for Tx of Borderline Resectable or Locally Advanced Pancreatic Cancer

Who this might be right for
Borderline Resectable Pancreatic AdenocarcinomaLocally Advanced Pancreatic Ductal AdenocarcinomaLocally Advanced Unresectable Pancreatic Adenocarcinoma+4 more
University of Utah 22
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06573398
What this trial is testing

Radiotherapy With Sequential Chemotherapy Combined With PD-1 Inhibitor and Thymalfasin for BRPC

Who this might be right for
Carcinoma, Pancreatic Ductal
Ruijin Hospital 20
Large-scale testing (Phase 3)Study completedNCT01458717
What this trial is testing

Neoadjuvant Chemoradiation in Patients With Borderline Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Seoul National University Hospital 58
Testing effectiveness (Phase 2)Study completedNCT01560949
What this trial is testing

Preoperative Folfirinox, Radiation Therapy for Resectable Adenocarcinoma of the Pancreas

Who this might be right for
Pancreatic Cancer
M.D. Anderson Cancer Center 34
Testing effectiveness (Phase 2)Study completedNCT01591733
What this trial is testing

FOLFIRINOX + RT for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Massachusetts General Hospital 48
Not applicableUnknownNCT05511116
What this trial is testing

Neoadjuvant Treatment of Resectable or Locally Advanced Borderline Pancreatic Adenocarcinoma: Reproducibility of Tumor Measurement in CT VS MRI

Who this might be right for
Pancreas CancerAdenocarcinoma
Fondation Hôpital Saint-Joseph 48
Large-scale testing (Phase 3)Looking for participantsNCT07436741
What this trial is testing

Surufatinib Plus Gemcitabine and Nab-paclitaxel vs. Gemcitabine Plus Nab-paclitaxel in Neoadjuvant Therapy for High - Risk Resectable or Borderline Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer, Adult
Tianjin Medical University Cancer Institute and Hospital 106
Testing effectiveness (Phase 2)Looking for participantsNCT06384560
What this trial is testing

Neoadjuvant Triple Therapy for (Borderline) Resectable Pancreatic Cancer (PREOPANC-5)

Who this might be right for
Localized Pancreatic AdenocarcinomaBorderline Resectable Pancreatic AdenocarcinomaResectable Pancreatic Adenocarcinoma
Amsterdam UMC, location VUmc 66
Not applicableUnknownNCT06206382
What this trial is testing

Surgical Results of Resection of Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreas Cancer
Assiut University 80
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07705919
What this trial is testing

DCE-MRI for Neoadjuvant Treatment Assessment in Patients With Borderline Resectable Pancreatic Cancer

Who this might be right for
Borderline Resectable Pancreatic Ductal Adenocarcinoma
Ohio State University Comprehensive Cancer Center 50
Early research (Phase 1)Study completedNCT01413022
What this trial is testing

FOLFIRINOX Plus PF-04136309 in Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Neoplasms
Washington University School of Medicine 44
Testing effectiveness (Phase 2)Ended earlyNCT01688336
What this trial is testing

FOLFIRINOX for Unresectable Locally Advanced and Borderline Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
UNC Lineberger Comprehensive Cancer Center 9
Not applicableUnknownNCT03443921
What this trial is testing

Divestment for Artery-involved Pancreatic Cancer

Who this might be right for
Pancreatic CancerLocally Advanced Pancreatic CancerNeoadjuvant Therapy+1 more
The First Affiliated Hospital with Nanjing Medical University 122
Not applicableLooking for participantsNCT06595160
What this trial is testing

Determining the Link Between Dietary Patterns, Fecal Microbiome and Response to Neoadjuvant Chemotherapy

Who this might be right for
Borderline Resectable Pancreatic Ductal AdenocarcinomaResectable Pancreatic Ductal AdenocarcinomaStage I Pancreatic Cancer AJCC v8
Emory University 87
Testing effectiveness (Phase 2)Study completedNCT02723331
What this trial is testing

Perioperative Therapy for Resectable and Borderline-Resectable Pancreatic Adenocarcinoma With Molecular Correlates

Who this might be right for
Pancreatic CancerPancreatic AdenocarcinomaPancreas Ductal Adenocarcinoma
Academic Thoracic Oncology Medical Investigators Consortium 48
Testing effectiveness (Phase 2)Looking for participantsNCT07269626
What this trial is testing

PULSAR in Systemic Therapy for Pancreatic Cancer

Who this might be right for
Locally Advanced Pancreatic Ductal AdenocarcinomaBorderline Resectable Pancreatic Ductal AdenocarcinomaOligometastatic Pancreatic Ductal Adenocarcinoma
Samsung Medical Center 47
Testing effectiveness (Phase 2)WithdrawnNCT00728000
What this trial is testing

Phase II Study Of Neoadjuvant Chemotherapy In Borderline Resectable Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Adenocarcinoma
University of Cincinnati
Very early researchStudy completedNCT01821612
What this trial is testing

Chemotherapy and Radiation Therapy Before Surgery Followed by Gemcitabine in Treating Patients with Pancreatic Cancer

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic Cancer+2 more
Alliance for Clinical Trials in Oncology 23
Testing effectiveness (Phase 2)Ended earlyNCT03099265
What this trial is testing

Neoadjuvant Modified FOLFIRINOX and Stereotactic Body Radiation Therapy in Borderline Resectable Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Cancer
Yale University 9
Next Page